VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246 | -34.6% | 57 | 0.0% | 0.00% | – |
| Q2 2023 | $376 | -2.8% | 57 | 0.0% | 0.00% | – |
| Q1 2023 | $387 | -8.1% | 57 | 0.0% | 0.00% | – |
| Q4 2022 | $421 | -57.9% | 57 | -32.9% | 0.00% | – |
| Q3 2022 | $1,000 | -99.9% | 85 | -99.9% | 0.00% | -100.0% |
| Q2 2022 | $804,000 | +21.8% | 73,767 | +26.4% | 0.00% | +33.3% |
| Q1 2022 | $660,000 | -4.5% | 58,367 | +32.6% | 0.00% | 0.0% |
| Q4 2021 | $691,000 | -13.8% | 44,010 | -5.9% | 0.00% | -25.0% |
| Q3 2021 | $802,000 | -12.9% | 46,766 | +9.2% | 0.00% | 0.0% |
| Q2 2021 | $921,000 | +63.9% | 42,817 | +14.4% | 0.00% | +33.3% |
| Q1 2021 | $562,000 | +49.1% | 37,425 | +30.4% | 0.00% | +50.0% |
| Q4 2020 | $377,000 | +62.5% | 28,703 | +19.3% | 0.00% | +100.0% |
| Q3 2020 | $232,000 | +64.5% | 24,059 | +95.5% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | – | 12,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |